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Abstract The introduction of silver, either in the liquid
phase (as silver nitrate solution: Ag(L)) or in the solid
phase (as silver phosphate salt: Ag(S)) of calcium car-
bonate–calcium phosphate (CaCO3–CaP) bone cement, its
influence on the composition of the set cement (C-Ag(L)
and C-Ag(S) cements with a Ca/Ag atomic ratio equal to
10.3) and its biological properties were investigated. The
fine characterisation of the chemical setting of silver-doped
and reference cements was performed using FTIR
spectroscopy. We showed that the formation of apatite
was enhanced from the first hours of maturation of
C-Ag(L) cement in comparison with the reference cement,
whereas a longer period of maturation (about 10 h) was
required to observe this increase for C-Ag(S) cement,
although in both cases, silver was present in the set
cements mainly as silver phosphate. The role of silver
nitrate on the setting chemical reaction is discussed and a
chemical scheme is proposed. Antibacterial activity tests
(S. aureus and S. epidermidis) and in vitro cytotoxicity
tests (human bone marrow stromal cells (HBMSC))
showed that silver-loaded CaCO3–CaP cements had anti-
bacterial properties (anti-adhesion and anti-biofilm forma-
tion) without a toxic effect on HBMSC cells, making
C-Ag(S) cement a promising candidate for the prevention
of bone implant-associated infections.
1 Introduction
The first self-setting calcium phosphate cements (CPC)
were introduced in the early 1980s as biomaterials for bone
repair and regeneration [1]. Since then, different CPCs
have been developed; their biomimetism and their excel-
lent osteoconductivity make them interesting candidates
for dental or orthopaedic applications. On the other hand,
their moulding ability allows for the optimal filling of
bone. Thus, many studies have been performed in order to
improve their physico-chemical properties and their bio-
logical behaviour. Nevertheless, some important issues still
need to be overcome. Among them, improved resorption
capability and better protection against implant-associated
infections are major challenges in this field [2, 3].
Calcium carbonate–calcium phosphate (CaCO3–CaP)
mixed cements have been presented as a promising
resorbable material for bone reconstruction [4]. Vaterite is a
metastable polymorph of calcium carbonate whose solubility
is higher than phosphocalcium apatite; a high proportion of
vaterite (i.e. 50 % w/w in the solid phase) is expected to
enhance the resorption of bone cement via faster physico-
chemical degradation.
Different strategies have been carried out in order to pre-
vent bacterial infection associated with the implantation of
CPCs [5]. Many studies were performed on the introduction
of antibiotics such as gentamicin, cephalexin or vancomycin
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[6–10]. However, if the addition of antibiotics is well-
accepted in the treatment of specific infections, it remains
controversial for preventive applications because of the cost
and risk of limited efficiency due to the potential resistance
of bacteria to the drug [3]. The use of Ca(OH)2 or alkali-
substituted phosphate reactants have also been proposed; the
released hydroxyl ions and the formation of highly alkaline
products during setting, respectively, provide an antibacterial
activity [11–13]. Nevertheless, such alkaline systems raise the
question of cytocompatibility and they cannot be transposed
to most mineral cement, particularly acidic ones.
On the other hand, silver has been widely used in medical
devices as a broad-spectrum antimicrobial agent with low
toxicity [14]. In particular, an antibacterial effect was
observed on Staphylococcus aureus (S. aureus), which is the
most frequent infective agent after prosthesis implantation
[15, 16]. It must be noted that, since the late 1970s, some cases
of silver-resistant bacteria have been identified, but they
remain rare and to our knowledge the main bacteria found in
usual post-operative infections are not concerned [17].
Among the developed medical devices, silver was
introduced by different methods into apatitic matrices
during apatite synthesis, for example by co-precipitation of
calcium hydroxide or calcium salt and silver nitrate with a
phosphate compound, by direct formation of silver-doped
hydroxyapatite (Ag-HA) coatings, or by an additional step
of impregnation of the hydroxyapatite (HA) gel or HA
coating in a solution of AgNO3 [18–26].
Although silver has been frequently introduced into
PMMA bone cements, only two silver-doped phosphocalcic
cements have been proposed recently [27–29]. Those apatitic
and brushitic cements were prepared by using silver-doped
tricalcium phosphate and showed a significant reduction in
the bacterial adherence of S. aureus and S. epidermidis but
decreased cytocompatibility in human osteoblast cell lines.
The present study focuses on the association of silver with
a CaCO3–CaP self-setting paste in order to confer the anti-
bacterial activity of this cement. Two methods of introduc-
tion were investigated: the addition of Ag3PO4, a third
powder component, into the solid phase or the use of a
solution of AgNO3 as the liquid phase. The objective of this
study was to evaluate the physical–chemical and biological
properties of such silver-loaded cements and to determine
the best candidate for a dental or orthopaedic application.
2 Materials and methods
2.1 Powders synthesis and characterisation
All syntheses were performed in aqueous media (deionised
water). Brushite (B), i.e. dicalcium phosphate dihydrate or
DCPD (CaHPO42H2O), was synthesised by double
decomposition between a calcium nitrate solution
(Ca(NO3)24H2O; 0.37 mol in 600 mL) and ammonium
dihydrogen phosphate (H2PO4NH4; 0.37 mol in 1.4 L and
20 mL of ammonium hydroxide solution at 20 % w/w).
The pH of the mixture was immediately adjusted to ca. 5.5
by the addition of extra ammonium hydroxide solution.
The white precipitate was then allowed to mature in solu-
tion, without stirring, for 5 h. It was finally filtered and
washed with 2 L of water. Vaterite (V), a polymorph of
calcium carbonate CaCO3, was also synthesised by double
decomposition by adding a solution of calcium chloride
(CaCl22H2O; 0.5 mol in 250 mL) in a solution of sodium
carbonate (Na2CO310H2O; 0.5 mol in 500 mL of deion-
ised water) using a peristaltic pump (12 mL/min). The
white precipitate was immediately filtered and washed with
1.5 L of water. After filtration and washing, the precipitates
were lyophilised and the powders were stored in a freezer.
Silver orthophosphate Ag3PO4 was prepared by double
decomposition between silver nitrate (AgNO3; 36 mmol in
200 mL) and disodium hydrogen phosphate (Na2HPO4;
12 mmol in 300 mL). The yellow precipitate was filtered
and washed with 500 mL of water. As Ag3PO4 is light
sensitive, all the glassware was covered by aluminium foil
to keep the solution and powder in darkness during syn-
thesis, drying and storage. Commercial silver nitrate salt
(AgNO3 99.9 %; Alfa Aesar
) was purchased and used
without further purification.
All the synthesised powders were characterised by
transmission Fourier transformed infrared spectroscopy
from KBr pellets (FTIR; Perkin-Elmer FTIR 1600 spec-
trometer), X-ray diffraction (XRD; Inel CPS 120 diffrac-
tometer) using a Co anticathode and by scanning electron
microscopy (SEM; Leo 435 VP microscope).
2.2 Cement preparation
The reference cement (C-REF cement) was obtained by
mixing deionised water as the liquid phase with the solid
phase composed of an equal mass of vaterite and brushite.
These reactive powders were first homogenised with a
pestle in a ceramic mortar.
Silver was introduced into the cement either in the solid
phase or in the liquid phase by means of silver salts with
different solubilities (Ag3PO4 and AgNO3). Silver-loaded
cement pastes were prepared by mixing an appropriate
amount of silver phosphate salt (Ag3PO4) with the solid
phase (C-Ag(S) cement), or by using a silver nitrate
(AgNO3) solution as the liquid phase (C-Ag(L) cement);
the amount of silver salt added in the cement formulation is
reported in Table 1. In both types of silver-loaded cements
prepared (C-Ag(S) and C-Ag(L)), the silver salt was
introduced in the cement formulation in order to reach a
Ca/Ag atomic ratio of 10.3 (Table 1). For the three cement
compositions (C-REF, C-Ag(S) and C-Ag(L)), the water/
solid weight ratio (W/S) was 0.55 (Table 1). After mixing,
the wet paste was placed in a water-saturated oven at 37 C
for setting and hardening.
For the cytotoxicity and microbiological tests, pellets of
the cements were prepared under the same conditions using
silicon rubber moulds (diameter: 10 mm). After setting and
drying, the surface of the pellets was polished with fine
sand paper (P1200) before c-ray sterilisation and in vitro
tests.
2.3 Cement characterisation
The cements were characterised by the FTIR, XRD and
SEM techniques. The setting time of the cement paste was
evaluated by the Gillmore needle method (standard ISO
9917-1:2007).
The chemical setting reaction was followed by FTIR
spectroscopy. For each composition, eight samples of
cement (0.9 ± 0.2 g) were formed from the same initial
paste immediately at the end of mixing. They were then
placed in an oven at 37 C in a humid atmosphere for
various periods of maturation (0, 1, 2, 3, 4, 7, 24 and 48 h)
and then lyophilised in order to remove the water and stop
the setting reaction. They were then weighed and analysed
by FTIR spectroscopy. The 850–450 cm-1 range of
wavenumbers contains several vibration bands character-
istic of the different phases involved in cement setting and
hardening (Table 2). Significant bands at 525, 603, 617 and
745 cm-1 were carefully chosen in order to evaluate the
relative ratios between brushite, apatite and vaterite
respectively. The silver orthophosphate phase could not be
identified in a relevant way by FTIR spectroscopy due to
the superimposition of bands, the very low amount of silver
phosphate in the cements and the possible precipitation of
AgBr within the KBr pellet. Thus, it was not taken into
account for the quantification. During the setting reaction,
the solid phase lost about 10 % of its weight (because of
CO2 degassing); we also assumed that the silver phase was
not involved in this loss. Some binary and ternary standard
samples were prepared by mixing known amounts of
brushite, vaterite and a synthetic nanocrystalline carbon-
ated apatite left to mature for 48 h.
Two domains, i.e. 850–700 and 700-450 cm-1, of the
FTIR spectrum of both cements and standards were
decomposed into different bands as reported in Table 2
using OriginPro 8.5 software. The baseline was fixed as a
straight line between the two minima of each studied
domain. An example of decomposition is shown in Fig. 1
for the C-REF cement after 7 h of maturation. The relative
areas of the FTIR bands characteristic of each phase
involved in the CaCO3–CaP cements were compared to
those of the standards. This allowed for an evaluation of
the content of the brushite, vaterite and apatite phases in
the studied cement.
2.4 Indirect cytotoxicity study
Cytotoxicity tests are essential before the in vivo evalua-
tion of a new biomaterial. The indirect cytotoxicity eval-
uation of silver-doped and reference CaCO3–CaP cement
compositions was assessed by an extraction method
according to NFEN30993-5 ISO 10993-5 [30].
Human bone marrow stroma cells, obtained from human
bone marrow according to Vilamitjana-Ame´de´e et al. [31]
with some modifications, were used to test the cytotoxicity
of the extracts and cultured in alpha-MEM without ascor-
bic acid (Invitrogen, France) containing 10 % (v/v) foetal
calf serum (FSC, Lonza, France). At passage 2, the cells
Table 1 Composition (weight in g) of the different prepared and studied cements: C-REF, C-Ag(S) and C-Ag(L) cements
Cements Solid phase (S) (g) Liquid phase (L) (g) Weight ratio Atomic ratios
Brushite (B) Vaterite (V) Ag3PO4 Water (W) AgNO3 W/S Ca/Ag Ca/P Ca/C
C-REF 0.50 0.50 – 0.55 – 0.55 – 2.72 1.58
C-Ag(S) 0.45 0.45 0.10 0.55 – 0.55 10.3 2.50 1.58
C-Ag(L) 0.50 0.50 – 0.55 0.13 0.55 10.3 2.72 1.58
Table 2 Assignments of the characteristic absorption bands used to
decompose the FTIR spectra in the 850–450 cm-1 domain
Position (cm-1) Phases Attribution
787 B P–O–H
745 V m2 CO3
2-
743 Ap–B Water libration
664 B Water libration
615 Ap Non-apatitic PO4
3-
601 Ap Apatitic PO4
3-
577 Ap–B Apatitic and brushitic PO4
560 Ap–
Ag
Apatitic and silver orthophosphate PO4
3-
533 Ap–B Non-apatitic and brushitic HPO4
2-
524 B HPO4
2-
B brushite, V vaterite, Ap carbonated apatite, Ag Ag3PO4
were seeded at a density of 40,000 cells/cm2 in 96-well
microtitre plates (Nunc, Denmark) and the culture was
maintained at 37 C for 96 h after cell plating. At sub-
confluency, the medium was replaced by the material
extraction vehicle. To obtain extraction vehicles, the
hardened cements loaded with silver were sterilised by c-
rays (25 kGy) and then immersed in alpha-MEM medium.
The ratio of the sample surface area to the volume of the
vehicle was 5 cm2/mL. Extractions were performed in
borosilicate glass tubes at 37 C for 24 h and this step was
repeated five times using the same approach. The extrac-
tion liquid was supplemented with 10 % (v/v) FCS.
Borosilicate tubes containing identical extraction vehicles
with either no material or a solution of phenol at a con-
centration of 64 g/L (known to be cytotoxic) were pro-
cessed under the same conditions to provide negative and
positive controls, respectively. The medium was replaced
by each extract solution supplemented with 10 % (v/v)
FCS and the plate was incubated for 24 h at 37 C. At the
end of the extract incubation period, tests were performed:
cell viability was assessed by the Neutral Red assay and
cell metabolic activity using the MTT assay [32, 33]. The
intensity of the colours obtained (red and blue, respec-
tively) is directly proportional to the viability and meta-
bolic activity of the cell population and inversely
proportional to the toxicity of the material. Indirect cyto-
toxicity tests were duplicated for each cement composition.
The mean values of absorbance measurements obtained
from colorimetric tests and their corresponding standard
deviations (±SD) were calculated. The results are expres-
sed as a percentage of the negative control (plastic) tested
during the same experiment.
2.5 Antibacterial in vitro test
In an attempt to define the effect of silver incorporation, the
antibacterial activity was investigated considering the
ability of staphylococci to adhere and colonise cement
surfaces. S. aureus CIP 4.83 and S. epidermidis CIP 68.21
(Institute Pasteur Collection, Paris, France) were grown in
24-well microplates containing reference and silver-loaded
cement pellets and 2 cm3 of modified biofilm broth (MBB),
as previously described by Khalilzadeh et al. [34]. The
model was chosen considering that the composition of
MBB and the renewal of the medium promotes adherent
but not planktonic cell growth with a biofilm structure.
After initial inoculation with 102 CFU, the MBB medium
was renewed at 2, 4, 6, 20, 24 and 48 h for S. aureus and at
6, 20, 24 and 48 h for S. epidermidis incubation at 37 C
after two gentle rinses with sterilised distilled water
(2 cm3). Biofilms were grown for 72 h. After the period of
growth (72 h), the wells and cement pellets were rinsed and
2 cm3 of distilled water were added. Adherent bacteria
were removed by scraping with a sterile spatula and CFU
numeration was performed on the solution. The entire
suspension was directly inoculated in trypcase soy agar
(Biome´rieux, Craponne, France) or tenfold diluted before
adding 100 lL in trypcase soy agar (incubation 48 h at
37 C). Each experiment was performed three times.
3 Results
3.1 Composition and structure
Figure 2 shows the XRD patterns of the cements after
setting and hardening. It appears that a biomimetic poorly
crystallised apatite was formed during the setting reaction
by the consumption of brushite and vaterite. Nevertheless,
some vaterite, initially introduced in excess, remained in
the final composition. The addition of silver as Ag3PO4
into the solid phase (C-Ag(S) cement) did not affect the
final composition: a similar content of apatite and vaterite
phases were identified by XRD analysis and silver
remained as a distinct crystalline phase (silver orthophos-
phate) in the cement. Interestingly, similar XRD patterns
were obtained for both the C-Ag(S) and C-Ag(L) cements.
Thus, it appears that silver orthophosphate, with a very low
solubility (1.5310-5 g/L at 19.5 C), precipitated when the
silver nitrate solution was added to the cement solid phase.
An instantaneous yellow coloration, characteristic of silver
orthophosphate, appeared at mixing time t0 and the XRD
data (not shown) confirmed the very fast precipitation of
Ag3PO4.
We followed the chemical setting of the different cements
by FTIR spectroscopy. The spectra of the three cement
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Fig. 1 Example of decomposition of the 850–450 cm-1 domain for
the cement C-REF after 7 h of maturation. The grey curve
corresponds to the experimental FTIR spectrum and the black curve
to the sum of the fitted bands. The circled bands are those used for the
evaluation of the relative composition between brushite (B), vaterite
(V) and apatite (Ap)
compositions at different maturation times (1, 4 and 48 h)
are shown in Fig. 3. We could clearly observe in Fig. 3 that
at 1 h and even more at 4 h the decrease in the characteristic
band of the brushite phase at 525 cm-1 in favour of an
increase in apatite characteristic bands at 603 and 617 cm-1:
this was significantly higher for C-Ag(L) than for the two
other types of cement, indicating faster chemical setting for
the C-Ag(L) cement. After 48 h, both silver-loaded cements
spectra showed that the brushite characteristic band at
525 cm-1 was no longer present, suggesting that this reac-
tive powder was totally consumed, whereas this band was
weak but still observable in the reference cement (C-REF)
spectrum.
To complete these observations, we performed a semi-
quantitative study to evaluate the formation of the apatite
phase during cement setting and hardening. Figure 4 shows
the evolution of the amount of apatite formed, determined
as described in the Materials and Methods section, and its
evolution during 48 h of maturation for the three types of
cement tested. It confirms that during the first 8 h, the
addition of Ag3PO4 in the solid phase did not seem to have
a significant impact on the formation of apatite, whereas
the increase in the amount of apatite was much faster for
C-Ag(L) cement. Between 8 and 24 h, C-Ag(S) caught up
to C-Ag(L), so that after 48 h, both cements containing
silver were totally set, in terms of the chemical setting
reaction, whereas for the C-REF cement, it took a longer
time for the setting reaction to reach the same level of
apatite content.
Complementarily, the physical setting of the cements
was measured using a Gillmore needle apparatus (Table 3).
For the C-REF cement, the initial and final setting times
were 1 h 15 min and 2 h 15 min, respectively. Despite
faster chemical reaction rates, no highly significant dif-
ferences were observed for the silver-containing cements
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Fig. 2 XRD patterns of the three types of hardened cements: C-REF,
C-Ag(S) and C-Ag(L)
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Fig. 3 Superimposition of
FTIR spectra (850–450 cm-1
domain) of the three types of
cements studied: C-REF,
C-Ag(S) and C-Ag(L) after
various periods of maturation
during setting (1, 4 and 48 h)
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Fig. 4 Evolution of the quantity of apatite formed (as determined by
FTIR spectroscopy) within the three types of cement (1 g of cement)
during setting. Each curve was fitted by the equation y = a * exp(-x/s) ?
y0, the main parameters are the following: C-REF: s = 7.2 ± 1.2 h
-1,
y0 = 65.5 ± 3.3 %; C-Ag(S): s = 9.2 ± 0.7 h
-1, y0 = 74.9 ± 1.7 %;
C-Ag(L): s = 5.5 ± 0.6 h-1, y0 = 70.9 ± 2.2 %
regarding the reference setting time. The introduction of
silver as AgNO3 solution (liquid phase) seemed to slightly
delay the initial cement setting time.
Backscatter SEM images of C-Ag(S) and C-Ag(L) cements
are presented in Fig. 5. Particles containing silver, which is the
heaviest element in the cement compositions tested, appeared
much brighter than the calcium phosphate and calcium car-
bonate phases. In the C-Ag(S) cement, the silver orthophos-
phate particles (ca. 2 lm) were homogeneously distributed
throughout the cement matrix, in relation to the initial
homogenisation of the reactive powders before the addition of
the liquid phase, whereas in the C-Ag(L) cement, silver
phosphate particles were smaller (a few hundred nanometres)
and do not appear homogeneously distributed. In addition, we
could see that both cements were microporous. Some mac-
ropores ([50 lm in diameter) were also present, in particular
in the C-Ag(L) cement.
3.2 Biological properties
3.2.1 In vitro cytotoxicity tests
Figure 6 shows the evolution of cell viability based on
extracts obtained sequentially every 24 h for the
C-Ag(S) cement. The extracts from this cement affected
the viability and metabolic activity of cells during the first
24 h only, as evidenced by the results obtained with both
the MTT and NR assays. For the following extractions, we
found a progressive increase in cell viability, but no sig-
nificant variation in their metabolic activity, which sug-
gests that with successive extractions, the C-Ag(S) cement
remained non-cytotoxic, especially after the fifth extraction
of the functionalised cement. Similar results were obtained
for the C-Ag(L) cement (data not shown).
3.2.2 Antibacterial in vitro tests
Table 4 presents the CFU enumeration per cement pellet
after 72 h of incubation with S. aureus CIP 4.83 and
S. epidermidis CIP 68.21.
For both strains of staphylococci tested, which are the
main species involved in bone-implant infections, we could
observe a dramatically decrease in bacterial numeration
(anti-adhesion and anti-biofilm formation effect) since
0 CFU of adherent bacteria were obtained for the
C-Ag(S) cement (P \ 0.001) whereas values with the ref-
erence cement (control) were similar to those obtained
directly in wells with no cement. Log reductions were
higher than 6 in all the assays. Similar results were
obtained for the C-Ag(L) cement (data not presented).
4 Discussion
4.1 Composition and setting of silver-loaded cements
In a previous study, it was shown that the setting of the
calcium carbonate–calcium phosphate mixed cement
Table 3 Setting time of the cements measured by the Gillmore
needle apparatus
Initial setting timea Final setting timea
C-REF 1 h 15 min 2 h 15 min
C-Ag(S) 1 h 15 min 2 h 00 min
C-Ag(L) 1 h 30 min 2 h 15 min
a Measurements were performed every 15 min and in triplicate for
each type of cement tested. Thus, the uncertainty of the values
is ± 15 min
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Fig. 5 SEM images (backscattered electrons) of C-Ag(S) and
C-Ag(L) cements showing the distribution of silver (bright dots) into
both types of cement
(C-REF) leads to the formation of a biomimetic nano-
crystalline apatite by a dissolution-reprecipitation reaction
[35]. In this nanocrystalline apatite, some of the PO4
3-
anions can be substituted by the divalent anions HPO4
2-
and CO3
2- also present in the self-setting system, thus
creating calcium and hydroxyl vacancies to maintain the
electroneutrality of the solid. According to the literature,
and considering our self-setting system, we can assume that
the general chemical formula of the apatite formed
is Ca10-(x?y)(PO4)6-(x?y)(HPO4)x(CO3)y(OH)2-(x?y) with
0 B x ? y B 2 [36]. Thus, the main chemical reactions
involved in the studied cement (dissolution of brushite and
vaterite (Eqs. 1, 2), the reaction between hydrogenophos-
phate and carbonate ions (Eq. 3) and the reprecipitation of
apatite (Eq. 4)) are represented by the following equations:
CaHPO4  2H2O ! Ca2þ þ HPO24 þ 2H2O ð1Þ
CaCO3 ! Ca2þ þ CO23 ð2Þ
2HPO24 þ CO23 ! 2PO34 þ CO2ðgÞ þ H2O ð3Þ
ð10  x  yÞCa2þ þ ð6  x  yÞPO34 þ xHPO24
þ yCO23 þ ð2  x  yÞ H2O ! Ca10xyðPO4Þ6xy
ðHPO4ÞxðCO3ÞyðOHÞ2xy þ ð2  x  yÞHþ ð4Þ
According to these four equations, the global system can be
modelled as follows:
ð6  yÞCaHPO4  2H2O þ ð4  xÞCaCO3
! Ca10xyðPO4Þ6xyðHPO4ÞxðCO3ÞyðOHÞ2xy
þ ð4  x  yÞCO2ðgÞ þ ð14  2yÞH2O ð5Þ
The formation of carbon dioxide (Eqs. 3, 5) can explained
the presence of macropores observed within the set cement
(Fig. 5).
In the present study, we showed that the introduction of
a silver salt into the cement composition did not change the
reaction mechanism: brushite dissolved and reacted with
some vaterite to form an apatite phase (Fig. 2). Neverthe-
less, FTIR spectroscopy semi-quantitative analysis
revealed a slight change in the setting kinetics, as the set-
ting reaction (chemical setting) rate appeared faster for the
cements containing silver (Fig. 2), whereas the setting time
(physical setting) was unchanged for C-Ag(S) and slightly
longer for C-Ag(L) (Table 3). It shall be recalled that the
physical setting time, corresponding to paste hardening,
although related to the chemical reactions involved, does
not superimpose with the advancement of these chemical
reactions. We discuss hereafter the chemical and physical
processes leading to the setting of these cements.
As mentioned before, Ag3PO4, introduced in the
C-Ag(S) cement or immediately formed in the
C-Ag(L) cement, has a low solubility, much lower, com-
paratively, than that of brushite and vaterite. Although it
may not induce a major change in the dissolution-repreci-
pitation reactions, it could have an impact on ion equilibrium
involved in these processes.
In the case of the C-Ag(L) cement, the precipitation of
Ag3PO4 observed immediately after the addition of silver
nitrate solution to the cement reactive powders mixture
induced, on the one hand, the beginning of the consump-
tion of phosphate ions from the brushite, consistent with
the earlier decrease in the phosphate band after 1 and 4 h
(Fig. 2) and, on the other hand, an acidification of the
medium (Eq. 6). Since Ca(NO3)2 is highly soluble
(1.44 9 103 g/L at 25 C), calcium ions are more readily
available to form some apatitic nuclei than in the C-REF
cement (Eq. 7). The acidification of the medium can also
favour the dissolution of the reactants, particularly acting
on vaterite by an acid–base reaction (Eq. 8), which leads to
the release of carbon dioxide and the regeneration of
Ca(NO3)2 which was initially involved in the precipitation
of apatite. Given Eqs. (7) and (8), it appears that Ca(NO3)2
could play the role of a catalyst in the self-setting system,
Fig. 6 Indirect cytotoxicity evaluation. Cell viability (neutral red
(NR) assay) and cell metabolic activity (MTT assay) of cells
incubated for 24 h at 37 C in five different extracts obtained by
successive extractions. Five extractions of C-Ag(S) cement in the
vehicle medium were performed every 24 h and are designated in the
figure as 24 (1) to 24 (5). Results are expressed as % of the negative
control material (plastic)
Table 4 Log CFU of adherent bacteria (S. aureus CIP 4.83 and S.
epidermidis CIP 68.21) after 72 h of incubation with the reference
(control) and silver-loaded (C-Ag(S)) cement pellets (mean ± SD;
n = 3)
Reference cement C-Ag(S) cement
S. aureus 6.98 ± 0.12 \3
P value (C vs. E) \0.001
S. epidermidis 6.86 ± 0.08 \3
P value (C vs. E) \0.001
as described in Fig. 7, until the complete dissolution of
brushite, the limiting reactant. Its involvement could
explain the faster precipitation of apatite observed by FTIR
spectroscopy (Fig. 3).
3AgNO3 þ CaHPO4  2H2O ! Ag3PO4 þ CaðNO3Þ2
þ HNO3 þ 2H2O ð6Þ
ð4  x  yÞCaðNO3Þ2 þ ð6  yÞCaHPO4  2H2O
þ yCaCO3 ! Ca10xyðPO4Þ6xyðHPO4ÞxðCO3Þy
ðOHÞ2xy þ 2ð4  x  yÞHNO3 þ ð10 þ x  yÞH2O
ð7Þ
CaCO3 þ 2HNO3 ! CaðNO3Þ2 þ CO2ðgÞ þ H2O ð8Þ
In the case of the C-Ag(S) cement, the low solubility of
Ag3PO4 introduced directly to the reactive powder mixture
(solid phase) made it a ‘‘spectator’’ phase at the beginning
of the setting process, in agreement with the absence of a
significant influence noticed on chemical (Fig. 2) and
physical (Table 3) setting. However, during the setting
reaction, apatite was formed, hence inducing an acidifi-
cation of the medium (Eq. (4)). This acidification might
transiently favour the dissolution of silver phosphate. On
the XRD pattern, the relative intensity of Ag3PO4 appeared
to decrease during setting (data not shown), and no addi-
tional phase was identified. An increased concentration of
phosphate ions will favour the formation of apatite. On the
other hand, although no shift of the XRD peaks can be
clearly observed, some Ag? ions could probably be
incorporated into the cationic lattice of the apatite. This
may also accelerate the precipitation process, as observed
after about 10 h of maturation (Fig. 4). Vandecandelaere
studied the conditions of formation of silver-doped nano-
crystalline apatites and showed that neutral and alkaline
conditions allowed for obtaining silver-doped nanocrys-
talline apatites (more Ag incorporated at neutral pH),
whereas acidic conditions favoured the precipitation of
silver phosphate [37]. In addition, this study revealed a
slight increase in apatite crystal length when silver was
incorporated into the nanocrystalline apatite structure.
However, no inhibitory or promoter effect of the presence
of silver on nanocrystalline apatite crystal growth has been
demonstrated.
The setting and hardening of cements is a complex
phenomenon, and is not always correlated with the chem-
ical reaction rate involved in the setting process: while
during the first 12 h of cement maturation, apatite was
formed more rapidly in the C-Ag(L) cement than in the
C-Ag(S) or C-REF cements (Fig. 4), hardening took
slightly longer (higher initial setting time, Table 3). The
more acidic initial medium and/or the presence of silver
might lead to smaller crystallites of apatite or to a greater
disorder of the structure, which could explain the slight
delay in the physical entanglement of particles and thus of
hardening.
The backscatter mode SEM images showed two major
differences in C-Ag(S) and C-Ag(L) cement microstruc-
ture: the size of the silver-rich particles (2 lm and a few
hundred nanometres respectively) and their distribution.
These two key parameters could have an impact on the
antibacterial activity of the cement. Homogeneity of the
distribution of silver is of course necessary in order to
control the local concentration of the antibacterial agent in
the material. It would be necessary to optimise the mixing
time and processing of the paste of the C-Ag(L) cement in
order to better homogenise the distribution of the silver
phosphate formed in situ. The size of the particles can be
discussed in terms of solubility: smaller particles will
probably have a higher rate of solubilisation and thus faster
kinetics of Ag? release. Our objective was to obtain a
preventive effect of silver and to avoid any bacterial
growth on the material. For this application, it would be
better to maintain a sufficient concentration of silver on the
surface of the materials, avoiding rapid release. Consider-
ing these two aspects, and given that there were no major
differences in the physico-chemical properties between the
two silver-loaded cements, C-Ag(S) appears to be better
candidate as bone substitute, as it did not introduce any
other counter ions such as nitrate in the cement
composition.
4.2 Biological properties of silver-loaded cements
The preliminary study on the in vitro biological properties
showed that silver-loaded CaCO3–CaP cements had
Fig. 7 Schematic
representation of the catalytic
role of Ca(NO3)2 in apatite
precipitation within the
C-Ag(L) cement
antibacterial properties (anti-adhesion and anti-biofilm for-
mation) without cytotoxic effects on human bone marrow
stromal cells after several washings of the cements, even if a
high dose of Ag was incorporated within cement (Ag/Ca
atomic ratio equal to 9.7 %).
The significant decrease in cell viability and metabolic
activity observed for cells in contact with the first extract
(first 24 h) suggests that a burst release of Ag should occur
during the equilibration of the C-Ag(S) cement with the
medium (alpha-MEM) at a high dose, such that cell via-
bility and metabolic activity were affected. However, for
the following extracts, cell viability as well metabolic
activity were restored, suggesting that with the equilibra-
tion of the cements in alpha-MEM, HBMS cells are able to
grow and to proliferate in contact with the extracts. Suc-
cessive washings of CaP cements or ceramics are needed
for equilibrating the materials before cell seeding or met-
abolic activity test. Considering the dynamic renewal of
biological fluids in vivo and the homogeneous distribution
of silver within the C-Ag(S) cement observed by micros-
copy (Fig. 4), we can expect good cytocompatibility of this
cement even in the early period after implantation.
The introduction of silver as an antibacterial agent in
hydroxyapatite and brushite bone cements has been
reported by Ewald et al. [29], who used silver-doped TCP
(a-or b-TCP, respectively) as reactive powders to prepare
both cements. They showed that silver-doped brushite
cement (Ag/Ca = 0.6 %) was the most efficient cement
with regards to two strains of staphylococci, but this
cement was also cytotoxic to osteoblasts in which activity
began to recover only after 7 days of culture. This
behaviour may be related to the high solubility of brushite
under biological conditions, which should in turn contrib-
ute to the release of a high amount of silver into the cell
culture medium. In addition, the probable hydrolysis of
brushite into apatite in vivo may generate locally an acidic
pH favouring Ag? release. However, the possibility of
precipitating a poor soluble silver phosphate after brushite
hydrolysis was not considered by the authors although it
may explain the recovery of cell activity after 7 days.
The dose of silver incorporated in the CaCO3–CaP
cements was high, but this can be optimised with regards to
the antibacterial properties and cytocompatibility of the
biomaterial. In addition, the route of introduction proposed
in the present study (silver salt added as a separate ingre-
dient within the solid or liquid phase) has the advantage of
allowing the dose of antibacterial agent to be adapted
during surgery and then delivered locally depending on the
application and the patient. Biological activity (antibacte-
rial and cytotoxicity) of silver associated or not to
hydroxyapatite has been earlier described and explored
[15, 20, 21]. The presented assays had to be considered as
preliminary results to check the maintenance of known
efficiency when silver is incorporated in calcium carbon-
ate–calcium phosphate bone cement. Antimicrobial assays
were performed in conditions allowing biofilm formation
but not planktonic growth, because such adherent bacteria
are significantly more resistant to immune system and
antibiotics treatments. In addition, these conditions are
more representative of the pathologic situation since bio-
film formation is required to induce chronic bones infec-
tions [38]. Pellets including the tested silver amount
displayed some strong anti-adhesive and/or anti-biofilm
formation exerted by silver associated with a CaCO3–CaP
cement on S. aureus and S. epidermidis, two major bone
pathogens [39, 40]. Our protocol allowed us to get a
detection limit as low as we were able to assess no CFU
from the cement surface after 72 h of incubation, whereas
more than 106 CFU were detected for control cement
pellets. The observed effects for such components can be
expected to be reproducible in long term in vivo condi-
tions, because of the total adhesion and biofilm formation
inhibition, even after 3 days of contact with an initial
inoculum of 102 CFU/cm2, which can be considered as an
in vivo worth case. A thorough study focusing on the
release properties (Ag release) and on the effect of Ag dose
on the biological properties of these cements is in progress
and will be presented in another paper.
Local delivery of the antibacterial agent presents an
alternative to the use of high and daily doses delivered
systemically and the toxicity or side effects associated with
this mode of drug administration.
5 Conclusion
This study contributes to understanding the complex
chemical reactions involved in silver-doped CaCO3–CaP
cement paste setting, and we proposed a chemical scheme
involving calcium nitrate as a catalytic agent in apatite
precipitation during C-Ag(L) cement setting. In vitro bio-
logical tests revealed the antibacterial properties of these
cements and their non-cytotoxicity after washing, making
silver-doped CaCO3–CaP cement a promising bone sub-
stitute material to reduce implant-associated infections.
Interestingly, we can take advantage of the two routes of
introduction of silver as a separate ingredient in the cement
formulation to adapt the dose of antibacterial agent up to
the final step, i.e. during surgery.
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